The acquiring company is part of pharmaceutical group A&D Pharma, owned by Penta Investments.
Teva Pharmaceuticals develops, produces and sells generic and innovative medicines.
Romania's antitrust body has authorized the deal whereby A&D Pharma Marketing&Sales SRL takes over assets from Teva Pharmaceuticals SRL (Teva), mainly consisting of wholesale contracts concluded by Teva.